Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven research firms that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $19.17.
Several analysts recently commented on SBRA shares. Mizuho restated a “neutral” rating and set a $20.00 price target on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Citizens Jmp raised shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. Truist Financial cut shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating and lowered their price target for the company from $18.00 to $17.00 in a report on Friday, January 17th. Finally, JMP Securities upgraded Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a report on Tuesday, January 7th.
Read Our Latest Analysis on Sabra Health Care REIT
Institutional Investors Weigh In On Sabra Health Care REIT
Sabra Health Care REIT Price Performance
SBRA opened at $17.09 on Thursday. Sabra Health Care REIT has a 12-month low of $13.31 and a 12-month high of $20.03. The company has a quick ratio of 4.16, a current ratio of 4.32 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $4.07 billion, a P/E ratio of 32.25, a PEG ratio of 1.97 and a beta of 1.27. The stock has a fifty day moving average of $16.77 and a 200-day moving average of $17.64.
Sabra Health Care REIT (NASDAQ:SBRA – Get Free Report) last announced its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.36. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The firm had revenue of $182.35 million during the quarter, compared to the consensus estimate of $178.01 million. Equities analysts forecast that Sabra Health Care REIT will post 1.45 EPS for the current fiscal year.
Sabra Health Care REIT Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Friday, February 14th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.02%. Sabra Health Care REIT’s dividend payout ratio is currently 226.42%.
Sabra Health Care REIT Company Profile
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Stories
- Five stocks we like better than Sabra Health Care REIT
- 3 REITs to Buy and Hold for the Long Term
- Corporate Crawl: Where Business Trips Turn Into Party Nights?
- Stock Market Sectors: What Are They and How Many Are There?
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- How to Invest in the FAANG Stocks
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.